| 000 | 01737 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250515201141.0 | ||
| 264 | 0 | _c20100329 | |
| 008 | 201003s 0 0 eng d | ||
| 022 | _a1098-660X | ||
| 024 | 7 |
_a10.1128/JCM.01073-09 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSchildgen, Oliver | |
| 245 | 0 | 0 |
_aSelection and counterselection of the rtI233V adefovir resistance mutation during antiviral therapy. _h[electronic resource] |
| 260 |
_bJournal of clinical microbiology _cFeb 2010 |
||
| 300 |
_a631-4 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdenine _xanalogs & derivatives |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAmino Acid Sequence |
| 650 | 0 | 4 |
_aAmino Acid Substitution _xgenetics |
| 650 | 0 | 4 |
_aAntiviral Agents _xpharmacology |
| 650 | 0 | 4 | _aDrug Resistance, Viral |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGuanine _xanalogs & derivatives |
| 650 | 0 | 4 |
_aHepatitis B virus _xdrug effects |
| 650 | 0 | 4 |
_aHepatitis B, Chronic _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMolecular Sequence Data |
| 650 | 0 | 4 | _aMutation, Missense |
| 650 | 0 | 4 |
_aOrganophosphonates _xpharmacology |
| 650 | 0 | 4 | _aSelection, Genetic |
| 650 | 0 | 4 | _aSequence Alignment |
| 650 | 0 | 4 | _aTenofovir |
| 650 | 0 | 4 | _aTreatment Failure |
| 650 | 0 | 4 | _aViremia |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aOlotu, Cynthia | |
| 700 | 1 | _aFunk, Anneke | |
| 700 | 1 | _aZöllner, Bernhard | |
| 700 | 1 | _aHelm, Martin | |
| 700 | 1 | _aRockstroh, Jürgen Kurt | |
| 700 | 1 | _aSirma, Hüseyin | |
| 773 | 0 |
_tJournal of clinical microbiology _gvol. 48 _gno. 2 _gp. 631-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1128/JCM.01073-09 _zAvailable from publisher's website |
| 999 |
_c19389372 _d19389372 |
||